Compare Constellation Energy Corporation (CEG) vs Cassava Sciences Inc (FLNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Constellation Energy Corporation vs Cassava Sciences Inc — how do they compare? Constellation Energy Corporation trades at $279.53 (market cap $95.82B), while Cassava Sciences Inc trades at $0.97 (market cap $47.75M). The key difference: Constellation Energy Corporation is far larger — about 2006.7× Cassava Sciences Inc's market cap, and Constellation Energy Corporation pays a 0.63% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals.
| CEG | FLNA | |
|---|---|---|
Market Cap | $95.82B | $47.75M |
Sector | Energy | Health |
52-Week High | $403.95 | $4.64 |
52-Week Low | $236.50 | $0.87 |
Enterprise Value | $119.82B | -$34.93M |
Dividend Yield | 0.63% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Constellation Energy (CEG) trades at $269.89, up 3.37% with a bullish technical outlook. The stock shows strong fundamentals with Q2 2026 EPS beating estimates at $2.55 versus $2.29 expected, and the company raised its 2026 guidance. Recent news highlights new power deals, including a Walmart PPA, and the acquisition of Calpine, positioning CEG to benefit from AI-driven electricity demand.
The outlook is positive with a consensus price target of $333.14, implying significant upside. Key opportunities include nuclear energy's role in the AI power boom and strong cash flow generation. Risks involve execution of growth initiatives and potential regulatory changes affecting the utilities sector.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Constellation Energy Corporation
Constellation is the largest producer of carbon-free energy in the U.S. and a leading nuclear power plant operator. It provides sustainable electricity to millions of residential, public, and industrial customers.
Read more on CEG →About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →
